May Alakl
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Lucile AwadP Jandı́kJ CarmichaelDavid CunninghamP RougierJ-Y DouillardMatilde NavarroG. Gruia
- Journals
- Blood (3 papers)European Journal of Cancer (2 papers)The Oncologist (1 paper)Annals of Oncology (1 paper)The Lancet (1 paper)
- Partner nations
- FranceBelgiumUnited Kingdom
In The Last Decade
May Alakl
7 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Hepatology 847
- Oncology 2.4k
- Pulmonary and Respiratory Medicine 722
- Pathology and Forensic Medicine 354
- Cancer Research 207
Countries citing papers authored by May Alakl
This map shows the geographic impact of May Alakl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Alakl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Alakl more than expected).
Fields of papers citing papers by May Alakl
This network shows the impact of papers produced by May Alakl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Alakl. The network helps show where May Alakl may publish in the future.
Co-authors
The 25 scholars most cited alongside May Alakl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 1 | |
| 2 | 2010 | 96 | |
| 3 | 2008 | 2 | |
| 4 | 2001 | 117 | |
| 5 | Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Hit paper breakdown → | 2000 | 2530 |
| 6 | 1999 | 1 | |
| 7 | 1995 | 17 | |
| 8 | 1994 | 117 |
About May Alakl
May Alakl is a scholar working on Hematology, Hepatology, Oncology, Pharmacology and Dermatology, having authored 8 papers that have together received 2.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Multiple Myeloma Research and Treatments (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer therapeutics and mechanisms (1 paper), Advanced Breast Cancer Therapies (1 paper) and Peripheral Neuropathies and Disorders (1 paper). The work is most often cited by research in Hepatology (847 citations), Oncology (2.4k citations), Pulmonary and Respiratory Medicine (722 citations), Pathology and Forensic Medicine (354 citations) and Cancer Research (207 citations). May Alakl has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include Lucile Awad, P Jandı́k, J Carmichael, David Cunningham, P Rougier, J-Y Douillard, Matilde Navarro, G. Gruia, Timothy Iveson and Petr Karásek. Their work appears in journals such as Blood, European Journal of Cancer, The Oncologist, Annals of Oncology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.